Results 11 to 20 of about 55,120 (206)

The use of drug calendars for the diagnosis of cutaneous drug eruptions in the age of electronic medical records [PDF]

open access: yes, 2020
A morbilliform drug eruption is the most common condition leading to a dermatology consultation for a patient in the hospital. Timing is an important diagnostic tool since the onset of a skin rash usually takes place within days-to-weeks of the start of ...
Cohen, Philip R, Grossman, Marc E
core  

Therapeutic evaluation of homeopathic treatment for canine oral papillomatosis [PDF]

open access: yes, 2020
Aim: A study was conducted to evaluate the ameliorative potential of homeopathic drugs in combination (Sulfur 30C, Thuja 30C, Graphites 30C, and Psorinum 30C) in 16 dogs affected with oral papillomatosis which was not undergone any previous treatment ...
Kumar, M. Asok   +5 more
core   +2 more sources

Alopecia areata: a multifactorial autoimmune condition [PDF]

open access: yes, 2019
Alopecia areata is an autoimmune disease that results in non-scarring hair loss, and it is clinically characterised by small patches of baldness on the scalp and/or around the body. It can later progress to total loss of scalp hair (Alopecia totalis) and/
Butcher, John P.   +3 more
core   +1 more source

Value of patch tests in clindamycin-related drug eruptions [PDF]

open access: yes, 2011
Background. Patch tests help to confirm the aetiology of the cutaneous adverse drug reactions involving delayed hypersensitivity mechanisms, but the results vary with the pattern of skin reaction and the culprit drug. Objectives.
Brites, MM   +4 more
core   +1 more source

Lichenoid drug eruption

open access: yesDermatology Online Journal, 2009
A 78-year-old man presented with an eight-month history of folliculocentric, pink, hyperkeratotic papules and plaques with thick white scale that involved the entire body, with confluence on the buttocks and genitalia. A biopsy specimen demonstrated superficial and focal, mild perivascular and perifollicular, band-like lymphocytic infiltrate and ...
Brauer, Jeremy   +3 more
openaire   +4 more sources

A case of new-onset vitiligo in a patient on tofacitinib and brief review of paradoxical presentations with other novel targeted therapies [PDF]

open access: yes, 2020
With recent advancements in the understanding of vitiligo pathogenesis, Janus kinase (JAK) inhibitors have emerged as a promising new treatment modality, but their effects remain incompletely elucidated.
Alikhan, Mujahed   +4 more
core  

Human African trypanosomiasis [PDF]

open access: yes, 2009
Human African trypanosomiasis (sleeping sickness) occurs in sub-Saharan Africa. It is caused by the protozoan parasite Trypanosoma brucei, transmitted by tsetse flies.
Abel   +143 more
core   +2 more sources

An unusual presentation of a case of human psittacosis [PDF]

open access: yes, 2018
Background: Chlamydia psittaci is a gram-negative, obligate intracellular organism. Birds are the main reservoir, but also non-avian domestic animals and humans can be infected.
Boelens, Jerina   +7 more
core   +3 more sources

Patch testing in fixed drug eruptions: a 20-year review. [PDF]

open access: yes, 2011
BACKGROUND: The fixed drug eruption is a common adverse drug reaction. Clear identification of the culprit drug is not always possible in the clinical setting, and oral rechallenge may induce new lesions or severe reactions.
Andrade, P   +2 more
core   +1 more source

Bullous Pemphigoid-like Skin Eruption during Treatment with Rivaroxaban: A Clinical Case Study [PDF]

open access: yes, 2018
Little has been documented about hypersensitivity reactions caused by treatment with rivaroxaban. This paper reports a bullous pemphigoid-like skin eruption that occurred in a 76-year-old female patient during rivaroxaban treatment.
Almeida Ribeiro, Jose   +4 more
core   +2 more sources

Home - About - Disclaimer - Privacy